REGN
REGENERON’S AXOKINE PROMOTES WEIGHT LOSS IN STUDY OF OVERWEIGHT AND OBESE PEOPLE WITH TYPE 2 DIABETES
Wednesday, April 16, 2003 1 min read
Key Takeaway: REGENERON’S AXOKINE PROMOTES WEIGHT LOSS IN STUDY OF OVERWEIGHT AND OBESE PEOPLE WITH TYPE 2 DIABETES
Full Press Release Details
REGENERON’S AXOKINE PROMOTES WEIGHT LOSS IN STUDY OF OVERWEIGHT AND OBESE PEOPLE WITH TYPE 2 DIABETES.